Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
연구종결
KCT0004754
자가인식 앱 피드백 시스템을 통한 edoxaban 약물 순응도 향상 연구: 무작위대조군연구
500
Enrollment(s)
1
Study location(s)
중재연구 (해당사항없음)
TERMINATED
NCT06231693
Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil
2
Enrollment(s)
2
Study location(s)
OBSERVATIONAL (None)
Breast Cancer
COMPLETED
NCT05149014
Safety, Effectiveness and Quality of Life of Trastuzumab Deruxtecan in Patients with HER2+ Breast Cancer
306
Enrollment(s)
1
Study location(s)
OBSERVATIONAL (None)
HER2-positive Breast Cancer
NOT_YET_RECRUITING
NCT06613191
Colonoscopy and Antiplatelet Therapy Trial
100
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Arterial Disease (CAD)
Peripheral Vascular Disease
RECRUITING
NCT04553770
Trastuzumab Deruxtecan Alone or in Combination with Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
88
Enrollment(s)
9
Study location(s)
INTERVENTIONAL (PHASE2)
Early-stage Breast Cancer
Hormone Receptor Positive Breast Carcinoma
Invasive Breast Cancer
Stage II Breast Cancer
Stage IIA Breast Cancer
Stage IIB Breast Cancer
Stage III Breast Cancer
COMPLETED
NCT03248492
A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)
253
Enrollment(s)
99
Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer
RECRUITING
NCT06525298
EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors
144
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Advanced Solid Tumor
Homologous Recombination Deficiency
HRR Deficiency
ACTIVE_NOT_RECRUITING
NCT05804747
A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial Fibrillation
1,204
Enrollment(s)
33
Study location(s)
OBSERVATIONAL (None)
Atrial Fibrillation
21
22
23
24
25